DisGeNET5_gene_disease Home  

PubMed:12949798 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
12949798-6#61#64#diseaseC1704272 736-739 diseaseC1704272 denotes BPH
12949798-6#61#64#diseaseC1704272 736-739 diseaseC1704272 denotes BPH
12949798-0#30#34#gene8535 738-826 gene8535 denotes H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2
12949798-0#30#34#gene60528 738-826 gene60528 denotes H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2
12949798-0#30#34#gene7834 738-826 gene7834 denotes H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2
12949798-6#147#151#gene8535 822-826 gene8535 denotes HPC2
12949798-6#147#151#gene60528 822-826 gene60528 denotes HPC2
12949798-6#147#151#gene7834 822-826 gene7834 denotes HPC2
12949798-0#35#40#gene60528 827-832 gene60528 denotes ELAC2
12949798-6#152#157#gene60528 827-832 gene60528 denotes ELAC2
12949798-0#62#78#diseaseC0376358 1339-1599 diseaseC0376358 denotes patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter
12949798-0#62#78#diseaseC0376358 1339-1599 diseaseC0376358 denotes patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter
12949798-13#48#52#gene8535 1695-1699 gene8535 denotes HPC2
12949798-13#48#52#gene60528 1695-1699 gene60528 denotes HPC2
12949798-13#48#52#gene7834 1695-1699 gene7834 denotes HPC2
12949798-13#53#58#gene60528 1700-1705 gene60528 denotes ELAC2
12949798-13#75#78#diseaseC2931456 1722-1725 diseaseC2931456 denotes PCa
12949798-13#75#78#diseaseC2931456 1722-1725 diseaseC2931456 denotes PCa
147#151#gene6052861#64#diseaseC1704272 12949798-6#147#151#gene60528 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene6052861#64#diseaseC1704272 12949798-6#147#151#gene60528 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene783461#64#diseaseC1704272 12949798-6#147#151#gene7834 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene783461#64#diseaseC1704272 12949798-6#147#151#gene7834 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene853561#64#diseaseC1704272 12949798-6#147#151#gene8535 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene853561#64#diseaseC1704272 12949798-6#147#151#gene8535 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
152#157#gene6052861#64#diseaseC1704272 12949798-6#152#157#gene60528 12949798-6#61#64#diseaseC1704272 associated_with ELAC2,BPH
152#157#gene6052861#64#diseaseC1704272 12949798-6#152#157#gene60528 12949798-6#61#64#diseaseC1704272 associated_with ELAC2,BPH
30#34#gene6052862#78#diseaseC0376358 12949798-0#30#34#gene60528 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene6052862#78#diseaseC0376358 12949798-0#30#34#gene60528 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene783462#78#diseaseC0376358 12949798-0#30#34#gene7834 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene783462#78#diseaseC0376358 12949798-0#30#34#gene7834 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene853562#78#diseaseC0376358 12949798-0#30#34#gene8535 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene853562#78#diseaseC0376358 12949798-0#30#34#gene8535 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
35#40#gene6052862#78#diseaseC0376358 12949798-0#35#40#gene60528 12949798-0#62#78#diseaseC0376358 associated_with ELAC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
35#40#gene6052862#78#diseaseC0376358 12949798-0#35#40#gene60528 12949798-0#62#78#diseaseC0376358 associated_with ELAC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
48#52#gene6052875#78#diseaseC2931456 12949798-13#48#52#gene60528 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene6052875#78#diseaseC2931456 12949798-13#48#52#gene60528 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene783475#78#diseaseC2931456 12949798-13#48#52#gene7834 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene783475#78#diseaseC2931456 12949798-13#48#52#gene7834 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene853575#78#diseaseC2931456 12949798-13#48#52#gene8535 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene853575#78#diseaseC2931456 12949798-13#48#52#gene8535 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
53#58#gene6052875#78#diseaseC2931456 12949798-13#53#58#gene60528 12949798-13#75#78#diseaseC2931456 associated_with ELAC2,PCa
53#58#gene6052875#78#diseaseC2931456 12949798-13#53#58#gene60528 12949798-13#75#78#diseaseC2931456 associated_with ELAC2,PCa